0001140361-23-033483.txt : 20230706
0001140361-23-033483.hdr.sgml : 20230706
20230706173737
ACCESSION NUMBER: 0001140361-23-033483
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230703
FILED AS OF DATE: 20230706
DATE AS OF CHANGE: 20230706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Apelian David
CENTRAL INDEX KEY: 0001546842
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36183
FILM NUMBER: 231074601
MAIL ADDRESS:
STREET 1: C/O ACHILLION PHARMACEUTICALS, INC
STREET 2: 300 GEORGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eiger BioPharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001305253
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 361004130
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2155 PARK BOULEVARD
CITY: PALO ALTO
STATE: CA
ZIP: 94306
BUSINESS PHONE: 650-279-9845
MAIL ADDRESS:
STREET 1: 2155 PARK BOULEVARD
CITY: PALO ALTO
STATE: CA
ZIP: 94306
FORMER COMPANY:
FORMER CONFORMED NAME: Celladon Corp
DATE OF NAME CHANGE: 20041005
4
1
form4.xml
X0407
4
2023-07-03
0001305253
Eiger BioPharmaceuticals, Inc.
EIGR
0001546842
Apelian David
C/O EIGER BIOPHARMACEUTICALS, INC.
2155 PARK BLVD.
PALO ALTO
CA
94306
true
true
CEO
false
Stock Option (Right to Buy)
0.729
2023-07-03
4
A
0
750000
0
A
2033-07-02
Common Stock
750000
750000
D
The option vests in equal monthly installments over 48 months measured from July 3, 2023, subject to the Reporting Person's continuous service as of each such date.
/s/ David Apelian
2023-07-06